14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
WOK vs PAVS: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Paranovus Entertainment Technology Ltd. Class A (PAVS) is the stronger overall head-to-head candidate over WORK Medical Technology Group LTD Class A (WOK) in the Tradestie Institutional Equity Comparison Engine, winning 4–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). WOK carries a Unified Composite Score of 25.6/100 (SELL) at $1.23 (N/M Forward P/E, -41.7% operating margin), whereas PAVS carries 45.5/100 (HOLD) at $2.26 (N/M Forward P/E, -23.1% operating margin).
Technical & Structure Timing Caution: WOK trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 49.1); meanwhile PAVS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on WOK vs PAVS. Trailing 12-month operating profitability (WOK -41.7% vs PAVS -23.1%) and valuation multiples (WOK N/M vs PAVS N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Footwear & Accessories value chain with $2.2M market capitalization and -23.1% operating margin.
OpEx & R&D Reinvestment39.6% of Rev ($5.8M)
90D Engineering Disclosures0 Published
Investor FAQ WOK vs PAVS Key Questions & Quantitative Answers
As of Nov 16, 2026, Paranovus Entertainment Technology Ltd. Class A (PAVS) is the stronger overall head-to-head candidate over WORK Medical Technology Group LTD Class A (WOK) in the Tradestie Institutional Equity Comparison Engine, winning 4–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). WOK carries a Unified Composite Score of 25.6/100 (SELL) at $1.23 (N/M Forward P/E, -41.7% operating margin), whereas PAVS carries 45.5/100 (HOLD) at $2.26 (N/M Forward P/E, -23.1% operating margin). Technical & Structure Timing Caution: WOK trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 49.1); meanwhile PAVS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
PAVS leads the Growth & Scale pillar: WOK posts +19.1% YoY revenue growth and -95.0% YoY earnings growth on $11M TTM revenue (17.0% gross margin, -41.7% operating margin), compared with PAVS at +70798.0% YoY revenue growth and +0.0% YoY earnings growth on $15M TTM revenue (16.5% gross margin, -23.1% operating margin). On trailing 12-month operating scale, WOK generates $11M in USD-normalized revenue versus $15M for PAVS. In operating R&D and SG&A reinvestment, WOK deploys 58.7% of Rev ($6.3M) (0 90-day corporate R&D disclosures) versus 39.6% of Rev ($5.8M) (0 disclosures) for PAVS.
PAVS screens cheaper on headline valuation multiples. WOK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.5x EV/Revenue (-31.4% EBITDA margin), whereas PAVS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-8.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against WOK (-19.2% ROE) versus PAVS (-50.7% ROE) capital efficiency.
In options market volatility and institutional positioning, WOK carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (38.49β · 153% Vol realized risk). By comparison, PAVS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (113.43β · 116% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.